RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report
American Journal of Hematology · 2026
DOI: 10.1002/ajh.70200 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Hematology, 2026. Verfasst von Zaina Inam und 23 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Erythrocyte Transfusion, Hematopoietic Stem Cell Transplantation, Erythrocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Children's Healthcare of Atlanta, Children's National Hospital, Lurie Children's Hospital of Chicago, Alberta Children's Hospital.
Abstract (Originalsprache)
Patients with sickle cell disease (SCD) commonly receive red blood cell (RBC) transfusions and can become RBC alloimmunized. This study was designed to investigate if RBC alloimmunization before hematopoietic cell transplant (HCT) was associated with post‐HCT outcomes and transfusion support using the multicenter Sickle cell Transplant Advocacy and Research (STAR) retrospective registry. From a cohort of 229 pediatric patients with SCD who underwent human leukocyte antigen (HLA)‐matched related donor HCT with myeloablative or reduced intensity conditioning, 40 patients (17%) were RBC alloimmunized pre‐HCT. The RBC alloimmunized group had a significantly higher incidence of grade III‐IV acute graft‐versus‐host disease (GVHD) (15% vs. 3.7%, p = 0.013), which remained significant (OR 4.22, 95% CI, 1.19, 14.3; p = 0.027) when controlling for pre‐HCT RBC transfusion burden and conditioning intensity. Graft failure occurred in 10% of RBC alloimmunized patients compared with 2.6% of non‐alloimmunized patients, p = 0.052. Patients with RBC alloimmunization had lower 5‐year severe GVHD‐free, rejection‐free survival (69% vs. 88%, p = 0.004), which remained significant when controlling for age. Post‐HCT patients received a median 3 RBC units (IQR 2, 6) and 11 platelet transfusions (IQR 7, 19). Pre‐HCT RBC alloimmunization was associated with a greater requirement for post‐HCT platelet transfusions, but not post‐HCT RBC units transfused. We postulate that the observed associations of pre‐HCT RBC alloimmunization with severe acute GVHD and post‐HCT platelet transfusion burden are due to inherent immunologic characteristics that render patients at increased risk of developing multiple immune‐mediated complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Children's National Hospital, Washington, DC, USA.
- George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia, USA.
- Division of Pediatric Hematology, Oncology, Stem Cell and Regenerative Medicine, Stanford University, Palo Alto, California, USA.
- Pediatric Biostatics Core, Department of Pediatrics, Emory School of Medicine, Atlanta, Georgia, USA.
- Orlando Health - Arnold Palmer Hospital for Children, Orlando, Florida, USA.
ORCID-Profile: Jeanne E Hendrickson, Monica L Hulbert
Förderung
- Children's Healthcare of Atlanta
- Children's National Hospital
- Lurie Children's Hospital of Chicago, Alberta Children's Hospital
- Children's Hospital of Philadelphia
- St. Louis Children's Hospital
- Morgan Stanley Children's Hospital, Nationwide Children's Hospital
- Phoenix Children's Hospital
- Methodist's Children's Hospital
Zitieren
APA
Inam, Z., Stenger, E., John, T. D., Liu, K., Gillespie, S., Shah, R., Chellapandian, D., Bhatia, M., Chaudhury, S., Eckrich, M. J., Guilcher, G. M. T., Hendrickson, J. E., Hulbert, M. L., Jaroscak, J. J., Kasow, K. A., Camacho-Bydume, C., Ngwube, A., Olson, T. S., Rangarajan, H. G., …, & Nickel, R. S. (2026). RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report. American Journal of Hematology. https://doi.org/10.1002/ajh.70200
Vancouver
Inam Z, Stenger E, John TD, Liu K, Gillespie S, Shah R, et al. RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report. American Journal of Hematology. 2026. doi:10.1002/ajh.70200
BibTeX
@article{Inam2026,
author = {Inam, Zaina and Stenger, Elizabeth and John, Tami D and Liu, Katie and Gillespie, Scott and Shah, Rikin and Chellapandian, Deepakbabu and Bhatia, Monica and Chaudhury, Sonali and Eckrich, Michael J and Guilcher, Gregory M T and Hendrickson, Jeanne E and Hulbert, Monica L and Jaroscak, Jennifer J and Kasow, Kimberly A and Camacho-Bydume, Christine and Ngwube, Alexander and Olson, Timothy S and Rangarajan, Hemalatha G and Horan, John T and Krishnamurti, Lakshmanan and Shenoy, Shalini and Abraham, Allistair and Nickel, Robert Sheppard},
title = {RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report},
journal = {American Journal of Hematology},
year = {2026},
doi = {10.1002/ajh.70200}
}
EUVIMED